The aim of the present study was to investigate the patterns of psychopharmacological practices in a large sample (n=1815) of patients suffering from obsessive-compulsive disorder (OCD) referred to four Italian centres specialized in OCD, in comparison to available national and international guidelines.The centres of Turin, Milan and Rome were selected on the basis of their expertise in treating OCD by the coordinating centre (Pisa), and all complete a specific data sheet questionnaire about therapeutic status of patients. Results: Almost all patients referred to the centres of Milan, Pisa and Rome received psychotropic medications. Only 59.9 % received medications in Turin. Selective serotonin reuptake inhibitors (SSRIs) were the most used...
Background: Many randomized controlled trials of the pharmacotherapy and psychotherapy of obsessive-...
Obsessive compulsive disorder (OCD) is a condition with a prevalence of around 1-2% (3-4% in some st...
The present study reports the results of an open-label trial on the use of the combination of olanza...
Objective: the aim of the present study was to investigate the patterns of psychopharmacological pre...
The aim of the present study was to investigate psychopharmacological prescribing patterns in a larg...
The aim of the present study was to investigate psychopharmacological prescribing patterns in a larg...
Objectives: To assess rates of psychotropic medication use in patients with obsessive-compulsive dis...
Objective: It is unknown what next-step strategies are being used in clinical practice for patients ...
Objective: The objective of this study was to characterise international trends in the use of psycho...
Objective The objective of this study was to characterise international trends in the use of psyc...
Objective: The objective of this study was to characterise international trends in the use of psycho...
Methods: Researchers in the field of OCD were invited to contribute summary statistics on the charac...
Background: Obsessive-compulsive disorder (OCD) is associated with affective and cognitive symptoms ...
6nono abstractreservedmixedMarazziti, D.; Mucci, F.; Tundo, A.; Albert, U.; Dell’Osso, B.; Moroni, I...
The pharmacotherapy for obsessive-compulsive disorder (OCD) has started with clomipramine, a potent ...
Background: Many randomized controlled trials of the pharmacotherapy and psychotherapy of obsessive-...
Obsessive compulsive disorder (OCD) is a condition with a prevalence of around 1-2% (3-4% in some st...
The present study reports the results of an open-label trial on the use of the combination of olanza...
Objective: the aim of the present study was to investigate the patterns of psychopharmacological pre...
The aim of the present study was to investigate psychopharmacological prescribing patterns in a larg...
The aim of the present study was to investigate psychopharmacological prescribing patterns in a larg...
Objectives: To assess rates of psychotropic medication use in patients with obsessive-compulsive dis...
Objective: It is unknown what next-step strategies are being used in clinical practice for patients ...
Objective: The objective of this study was to characterise international trends in the use of psycho...
Objective The objective of this study was to characterise international trends in the use of psyc...
Objective: The objective of this study was to characterise international trends in the use of psycho...
Methods: Researchers in the field of OCD were invited to contribute summary statistics on the charac...
Background: Obsessive-compulsive disorder (OCD) is associated with affective and cognitive symptoms ...
6nono abstractreservedmixedMarazziti, D.; Mucci, F.; Tundo, A.; Albert, U.; Dell’Osso, B.; Moroni, I...
The pharmacotherapy for obsessive-compulsive disorder (OCD) has started with clomipramine, a potent ...
Background: Many randomized controlled trials of the pharmacotherapy and psychotherapy of obsessive-...
Obsessive compulsive disorder (OCD) is a condition with a prevalence of around 1-2% (3-4% in some st...
The present study reports the results of an open-label trial on the use of the combination of olanza...